Skip to main content
. 2019 Mar 8;19:54. doi: 10.1186/s12866-019-1416-8

Fig. 4.

Fig. 4

MIC (μg/ml) variations of a. Gentamicin, b. LL-37 and c. CAMA against two P. aeruginosa treated daily with half the MIC of these antimicrobial agents. MDRPA: multidrug-resistant Pseudomonas aeruginosa; w/o: without